Click Here To Print
Product Detail

20 Questions and Answers about Metastatic Castration- Resistant Prostate Cancer (mCRPC)

Ellsworth, Pamela MD
20 Questions and Answers about Metastatic Castration- Resistant Prostate Cancer (mCRPC) Cover Image
Pricing & Availability
Available: 0
List Price:$13.95


Other formats:
Book Information
Edition: 1st
Publisher: Jones & Bartlett Publishing
ISBN: 1-284-04836-5 (1284048365)
ISBN-13: 978-1-284-04836-0 (9781284048360)
New Edition: 1-284-17646-0
Format: Low Page Count
Binding: Softcover
Copyright: 2015
Publish Date: 09/14
Bookstore Series: 20 Questions & Answers (See all titles)
Weight: 0.32 Lbs.
Pages: 61
Carton Quantity: 72
Subject Class: C-H (Consumer Health)
Remarks:
A New Edition of this title is due 01/20
Return Policy: Returns accepted up to 10 months
Contributing Authors: View
 
Class Specifications
ISSN Series: Questions & Answers About
Discipline: Urogenital Sys
Subject Definition: Prostatic Neoplasms-Popular Works
NLM Class: WJ 752
LC Class: RC280
Abstract: Based on Jones & Bartlett Learning's acclaimed 100 Questions & Answers series, 20 Questions and Answers about Metastatic Castration-Resistant Prostate Cancer (mCRCP) provides authoritative and practical answers to the most common questions asked by men who have been diagnosed with prostate cancer which has proven to be resistant to initial therapies. Providing both doctor and patient perspectives, this easy-to-read book is a comprehensive guide to metastatic castration resistant prostate cancer, and is must-have for patients as well as their caregivers. Written by Dr. Pamela Ellsworth, a prominent urologist and best-selling author, 20 Questions and Answers about Metastatic Castration-Resistant Prostate Cancer (mCRCP) is an invaluable resource for anyone who has been impacted by prostate cancer.
close

Follow Matthews Book Co. on:
Follow Matthews Book Co. on Twitter

Copyright © 2001-2019 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews Privacy Statement